Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Edinburgh
Age
30–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age criteria as follows:
Native valve endocarditis \>30 years
Prosthetic valve endocarditis/device infection \>50 years
Non-infective post-operative patients \>65 years
Completion of informed consent
Established diagnosis of one of the conditions listed below:
I. Native valve infective endocarditis; established diagnosis by Dukes criteria II. Prosthetic valve or device-related infection; established diagnosis by Dukes criteria (in the case of valves), or by microbiological, haematological and biochemical grounds (in the case of device-related infection) III. Recent implant of prosthetic valve and/or cardiac device
You may not be if
Inability or unwilling to give informed consent
Women who are pregnant, breastfeeding or of child-bearing potential (women who have experienced menarche, are pre-menopausal and have not been sterilised) will not be enrolled into the trial
Major intercurrent illness with life-expectancy \<2 years
Renal dysfunction (eGFR less than or equal to 30ml/min/1.73m2)
Adverse reaction or hypersensitivity to 18F-FDG PET tracer
NYHA Class IV heart failure
Insulin-dependent diabetes mellitus
Patients with atrial fibrillation and poor rate control
Contraindications to MR for patients in the groups undergoing PET/MR including any patient with suspected metal in their eyes
Previous history of contrast allergy of adverse reactions (iodinated contrast in patients undergoing PET/CT and gadolinium in patients undergoing PET/MR)
Clareo Health | PET/MR Imaging In Patients With Infective Endocarditis
